A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3Hsiao‐Tuan Chao, Laurel A. Donnell‐Fink, Mariska Davids et al.|The American Journal of Human Genetics|2016Cited by 122
Germline AGO2 mutations impair RNA interference and human neurological developmentDavor Lessel, P. Ian Andrews, Daniela M. Zeitler et al.|Nature Communications|2020Cited by 102
Loss‐of‐function variants in <i>NFIA</i> provide further support that <i>NFIA</i> is a critical gene in 1p32‐p31 deletion syndrome: A four patient seriesAnya Revah‐Politi, Kwame Anyane‐Yeboa, Mythily Ganapathi et al.|American Journal of Medical Genetics Part A|2017Cited by 54
Expanding the phenotype of <scp><i>ASXL3</i></scp>‐related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in <scp><i>ASXL3</i></scp>Schaida Schirwani, Charlotte W. Ockeloen, Shadi Albaba et al.|American Journal of Medical Genetics Part A|2021Cited by 25
Clinical features and genotype–phenotype correlations in epilepsy patients with de novo <scp><i>DYNC1H1</i></scp> variantsClaudia Cuccurullo, Hormos Salimi Dafsari, Emanuele Cerulli Irelli et al.|Epilepsia|2024Cited by 7